SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-022188
Filing Date
2021-02-12
Accepted
2021-02-12 18:02:17
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm214979-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm214979-10_4seq1.xml 4 3677
  Complete submission text file 0001104659-21-022188.txt   5320
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SANKT-JACOBS-STRASSE 90 CH-9002 BASEL V8 4052
Business Address SANKT-JACOBS-STRASSE 90 CH-9002 BASEL V8 4052 61 3137965
SALMON Pharma GmbH (Reporting) CIK: 0001843677 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 21630479